-
公开(公告)号:US20140023616A1
公开(公告)日:2014-01-23
申请号:US13942501
申请日:2013-07-15
申请人: Todd Appleby , Hans G. Fliri , Andrew J. Kaets , Linos Lazarides , Richard L. Mackman , Simon N. Pettit , Karine G. Poullennec , Jonathan Sanvoisin , Victoria A. Steadman , Gregory M. Watt
发明人: Todd Appleby , Hans G. Fliri , Andrew J. Kaets , Linos Lazarides , Richard L. Mackman , Simon N. Pettit , Karine G. Poullennec , Jonathan Sanvoisin , Victoria A. Steadman , Gregory M. Watt
CPC分类号: A61K38/06 , A61K45/06 , C07D487/04 , C07D487/08 , C07D498/08 , C07D498/18 , C07K5/02 , C07K5/06052
摘要: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
摘要翻译: 提供式I化合物及其药学上可接受的盐和酯。 所提供的化合物,组合物和方法可用于治疗黄病毒科感染,特别是丙型肝炎感染。
-
公开(公告)号:US08513184B2
公开(公告)日:2013-08-20
申请号:US13315069
申请日:2011-12-08
申请人: Todd Appleby , Hans G. Fliri , Andrew J. Keats , Linos Lazarides , Richard L. Mackman , Simon N. Pettit , Karine G. Poullennec , Jonathan Sanvoisin , Victoria A. Steadman , Gregory M. Watt
发明人: Todd Appleby , Hans G. Fliri , Andrew J. Keats , Linos Lazarides , Richard L. Mackman , Simon N. Pettit , Karine G. Poullennec , Jonathan Sanvoisin , Victoria A. Steadman , Gregory M. Watt
CPC分类号: A61K38/06 , A61K45/06 , C07D487/04 , C07D487/08 , C07D498/08 , C07D498/18 , C07K5/02 , C07K5/06052
摘要: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
-
公开(公告)号:US20130022573A1
公开(公告)日:2013-01-24
申请号:US13315069
申请日:2011-12-08
申请人: Todd Appleby , Hans G. Fliri , Andrew J. Keats , Linos Lazarides , Richard L. Mackman , Simon N. Pettit , Karine G. Poullennec , Jonathan Sanvoisin , Victoria A. Steadman , Gregory M. Watt
发明人: Todd Appleby , Hans G. Fliri , Andrew J. Keats , Linos Lazarides , Richard L. Mackman , Simon N. Pettit , Karine G. Poullennec , Jonathan Sanvoisin , Victoria A. Steadman , Gregory M. Watt
CPC分类号: A61K38/06 , A61K45/06 , C07D487/04 , C07D487/08 , C07D498/08 , C07D498/18 , C07K5/02 , C07K5/06052
摘要: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
摘要翻译: 提供式I化合物及其药学上可接受的盐和酯。 所提供的化合物,组合物和方法可用于治疗黄病毒科感染,特别是丙型肝炎感染。
-
4.
公开(公告)号:US20110269715A1
公开(公告)日:2011-11-03
申请号:US13151675
申请日:2011-06-02
申请人: June Chen , Simon N. Pettit , Hans G. Fliri
发明人: June Chen , Simon N. Pettit , Hans G. Fliri
IPC分类号: A61K31/50 , A61K31/69 , A61K31/502 , A61P9/12 , A61K31/661 , A61K31/675 , A61K31/57 , A61P27/06 , A61K31/5377 , A61K31/542
CPC分类号: C07D211/70 , A61K31/05 , A61K31/122 , A61K31/34 , A61K31/35 , A61K31/381 , A61K31/382 , A61K31/435 , A61K31/4353 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/4523 , A61K31/50 , A61K31/501 , A61K31/502 , A61K31/5375 , C07C39/17 , C07C39/23 , C07D211/86 , C07D237/16 , C07D237/24
摘要: The present invention provides a method of treating glaucoma or ocular hypertension which comprises applying to the eye of a person in need thereof an amount sufficient to treat glaucoma or ocular hypertension of a compound of formula I wherein Y, Q, Z, R, R1 and R2 are as defined in the specification.The present invention further comprises pharmaceutical compositions, e.g. ophthalmic compositions, including said compound.
摘要翻译: 本发明提供治疗青光眼或高眼压症的方法,其包括向有需要的人的眼睛施用足以治疗式I化合物的青光眼或高眼压的量,其中Y,Q,Z,R,R 1和 R2如说明书中所定义。 本发明还包括药物组合物,例如 包括所述化合物的眼用组合物。
-
公开(公告)号:US07968711B2
公开(公告)日:2011-06-28
申请号:US11739183
申请日:2007-04-24
申请人: June Chen , Simon N. Pettit , Hans G. Fliri
发明人: June Chen , Simon N. Pettit , Hans G. Fliri
IPC分类号: C07D401/00 , C07D237/00 , C07D237/02 , C07D405/00
CPC分类号: C07D211/70 , A61K31/05 , A61K31/122 , A61K31/34 , A61K31/35 , A61K31/381 , A61K31/382 , A61K31/435 , A61K31/4353 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/4523 , A61K31/50 , A61K31/501 , A61K31/502 , A61K31/5375 , C07C39/17 , C07C39/23 , C07D211/86 , C07D237/16 , C07D237/24
摘要: The present invention provides a method of treating glaucoma or ocular hypertension which comprises applying to the eye of a person in need thereof an amount sufficient to treat glaucoma or ocular hypertension of a compound of formula I wherein Y, Q, Z, R, R1 and R2 are as defined in the specification. The present invention further comprises pharmaceutical compositions, e.g. ophthalmic compositions, including said compound.
摘要翻译: 本发明提供治疗青光眼或高眼压症的方法,其包括向有需要的人的眼睛施用足以治疗式I化合物的青光眼或高眼压的量,其中Y,Q,Z,R,R 1和 R2如说明书中所定义。 本发明还包括药物组合物,例如 包括所述化合物的眼用组合物。
-
公开(公告)号:US07868032B2
公开(公告)日:2011-01-11
申请号:US11869697
申请日:2007-10-09
申请人: David F. Woodward , Jenny W. Wang , Clive L. Cornell , Hans G. Fliri , Jose L. Martos , Simon N. Pettit
发明人: David F. Woodward , Jenny W. Wang , Clive L. Cornell , Hans G. Fliri , Jose L. Martos , Simon N. Pettit
IPC分类号: A61K31/422 , C07D263/30 , C07D311/02
CPC分类号: G01N33/5088 , C07D493/08
摘要: The present invention provides prostamide receptor antagonist compounds that may be represented by the general formula I wherein A, R1, R2, R3, R4 and R6 are as defined in the specification.
摘要翻译: 本发明提供可由通式I表示的前列腺酰胺受体拮抗剂化合物,其中A,R 1,R 2,R 3,R 4和R 6如说明书中所定义。
-
7.
公开(公告)号:US20070249596A1
公开(公告)日:2007-10-25
申请号:US11739183
申请日:2007-04-24
申请人: June Chen , Simon N. Pettit , Hans G. Fliri
发明人: June Chen , Simon N. Pettit , Hans G. Fliri
IPC分类号: A61K31/50 , A61K31/05 , A61K31/122 , A61K31/5375 , A61K31/435 , A61K31/445
CPC分类号: C07D211/70 , A61K31/05 , A61K31/122 , A61K31/34 , A61K31/35 , A61K31/381 , A61K31/382 , A61K31/435 , A61K31/4353 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/4523 , A61K31/50 , A61K31/501 , A61K31/502 , A61K31/5375 , C07C39/17 , C07C39/23 , C07D211/86 , C07D237/16 , C07D237/24
摘要: The present invention provides a method of treating glaucoma or ocular hypertension which comprises applying to the eye of a person in need thereof an amount sufficient to treat glaucoma or ocular hypertension of a compound of formula I wherein Y, Q, Z, R, R1 and R2 are as defined in the specification.The present invention further comprises pharmaceutical compositions, e.g. ophthalmic compositions, including said compound.
摘要翻译: 本发明提供治疗青光眼或高眼压症的方法,其包括向有需要的人的眼睛施用足以治疗式I化合物的青光眼或高眼压的量,其中Y,Q,Z,R,R' SUP> 1>和< 2>是如说明书中所定义的。 本发明还包括药物组合物,例如 包括所述化合物的眼用组合物。
-
公开(公告)号:US5405826A
公开(公告)日:1995-04-11
申请号:US3600
申请日:1993-01-13
IPC分类号: A01N43/90 , C07D471/04 , A01N43/58
CPC分类号: C07D471/04 , A01N43/90
摘要: Pyrido[2,3-d]pyridazin-5-one and pyrido[2,3-d]pyridazin-5-thione derivatives of general formula (I): ##STR1## wherein R and R.sup.1 independently represent hydrogen, optionally halogenated alkyl, alkenyl or alkynyl, optionally substituted heterocycle or a group --[CR.sup.41 R.sup.42 ].sub.n -(phenyl)-(R.sup.3).sub.q ;R.sup.2 represents halogen, optionally halogenated alkyl, alkenyl or alkynyl, CN; --CO.sub.2 R.sup.4 ; --S(O).sub.r R.sup.4 ; --NO.sub.2 ; --NR.sup.41 R.sup.42 ; --OH; --COR.sup.4, --S(O).sub.r R.sup.5, --CO.sub.2 R.sup.5, --OR.sup.5 ; --CONR.sup.41 R.sup.42, --OSO.sub.2 R.sup.5, --OSO.sub.2 R.sup.6, --OCH.sub.2 R.sup.5, --N(R.sup.41)COR.sup.6, --N(R.sup.41)SO.sub.2 R.sup.5, --N(R.sup.41)SO.sub.2 R.sup.6, --SO.sub.2 NR.sup.41 R.sup.42, optionally substituted phenyl, alkoxy or haloalkoxy;X represents oxygen or sulphur;R.sup.3 represents halogen, optionally halogenated alkyl, alkenyl, alkoxy, alkynyl, --OH, --S(O).sub.r R.sup.4, --CO.sub.2 R.sup.4, COR.sup.4, --CN, --NO.sub.2, --NR.sup.41 R.sup.42, --OR.sup.5 ; --CONR.sup.41 R.sup.42, --OSO.sub.2 R.sup.5, --OSO.sub.2 R.sup.6, --OCH.sub.2 R.sup.5, --N(R.sup.41)COR.sup.6, --N(R.sup.41)SO.sub.2 R.sup.5, --N(R.sup.41)SO.sub.2 R.sup.6 or --SO.sub.2 NR.sup.41 R.sup.42 ;R.sup.4 represents a hydrogen atom or optionally halogenated C.sub.1-6 alkyl;R.sup.41 and R.sup.42, which may be the same or different, each represents a hydrogen atom or optionally halogenated C.sub.1-4 alkyl;R.sup.5 represents a phenyl group optionally substituted by from one to five groups selected from halogen, nitro, cyano, R.sup.4 and --OR.sup.4 ;m represents zero or an integer from one to three;n represents zero, one or two; where n is two, the groups --(CR.sup.41 R.sup.42)-- may be the same or different;q represents zero or an integer from one to five; r represents zero, one or two;with the proviso that when m represents zero R and R.sup.1 do not simultaneously represent hydrogen;and agriculturally acceptable salts thereof are useful as herbicides.
摘要翻译: 通式(I)的吡啶并[2,3-d]哒嗪-5-酮和吡啶并[2,3-d]哒嗪-5-硫酮衍生物:前述氢,任选卤代烷基,烯基或炔基,任选取代的杂环或 基团 - [CR 41 R 42] n-(苯基) - (R 3)q; R 2表示卤素,任选卤代烷基,烯基或炔基,CN; -CO 2 R 4; -S(O)r R 4; -NO2; -NR41R42; -哦; -COR 4,-S(O)r R 5,-CO 2 R 5,-OR 5; -CONR 41 R 42,-OSO 2 R 5,-OSO 2 R 6,-OCH 2 R 5,-N(R 41)COR 6,-N(R 41)SO 2 R 5,-N(R 41)SO 2 R 6,-SO 2 NR 41 R 42,任选取代的苯基,烷氧基或卤代烷氧基; X表示氧或硫; R 3表示卤素,任选卤代烷基,烯基,烷氧基,炔基,-OH,-S(O)rR 4,-CO 2 R 4,COR 4,-CN,-NO 2,-NR 41 R 42,-OR 5; -CONR 41 R 42,-OSO 2 R 5,-OSO 2 R 6,-OCH 2 R 5,-N(R 41)COR 6,-N(R 41)SO 2 R 5,-N(R 41)SO 2 R 6或-SO 2 NR 41 R 42; R 4表示氢原子或任选卤代的C 1-6烷基; R 41和R 42可以相同或不同,各自表示氢原子或任选卤代的C 1-4烷基; R5表示任选被1至5个选自卤素,硝基,氰基,R 4和-OR 4的基团取代的苯基; m表示0或1到3的整数; n表示零,一或二; 其中n为2,基团 - (CR41R42)可以相同或不同; q表示0或1到5的整数; r表示零,一或二; 条件是当m表示零时R和R 1不同时表示氢; 和其农业上可接受的盐可用作除草剂。
-
公开(公告)号:US5371063A
公开(公告)日:1994-12-06
申请号:US191449
申请日:1994-02-03
IPC分类号: A01N43/80 , C07D261/06 , C07D261/08 , C07D261/18 , A01N43/74
CPC分类号: C07D261/18 , A01N43/80 , C07D261/08
摘要: The invention relates to 4-benzoylisoxazole derivatives of formula (I): ##STR1## wherein R represents hydrogen or --CO.sub.2 R.sup.4 ; R.sup.1 represents alkyl, haloalkyl or optionally substituted cycloalkyl;R.sup.2 represents halogen, alkyl, haloalkyl, alkyl substituted by one or more groups --OR.sup.5 ; ora group selected from nitro, cyano, --CO.sub.2 R.sup.5, --S(O).sub.p R.sup.6, --O(CH.sub.2).sub.m OR.sup.5, --COR.sup.5, --OR.sup.5 and --N(R.sup.8)SO.sub.2 R.sup.7 ;R.sup.3 represents --SO.sub.2 R.sup.7 ;X represents the oxygen atom;n represents zero or an integer from one to four;R.sup.4 represents alkyl or haloalkyl;R.sup.5 and R.sup.6, independently represent alkyl, haloalkyl or optionally substituted phenyl;R.sup.7 represents alkyl, haloalkyl, optionally substituted phenyl or --NR.sup.5 R.sup.6 ;R.sup.8 represents hydrogen, optionally halogenated alkyl, alkenyl or alkynyl; cycloalkyl, optionally substituted phenyl, --SO.sub.2 R.sup.6 or --OR.sup.5 ;p represents zero, one or two; andm represents an integer from one to three;and their use as herbicides is described.
摘要翻译: 本发明涉及式(I)的4-苯甲酰异恶唑衍生物:其中R表示氢或-CO 2 R 4; R1代表烷基,卤代烷基或任选取代的环烷基; R 2表示卤素,烷基,卤代烷基,被一个或多个基团-OR 5取代的烷基; 或选自硝基,氰基,-CO 2 R 5,-S(O)p R 6,-O(CH 2)mOR 5,-COR 5,-OR 5和-N(R 8)SO 2 R 7的基团; R3代表-SO2R7; X表示氧原子; n表示0或1到4的整数; R4代表烷基或卤代烷基; R5和R6独立地表示烷基,卤代烷基或任选取代的苯基; R 7表示烷基,卤代烷基,任选取代的苯基或-NR 5 R 6; R8表示氢,任选卤代烷基,烯基或炔基; 环烷基,任选取代的苯基,-SO 2 R 6或-OR 5; p表示零,一或二; m表示1〜3的整数, 并描述其作为除草剂的用途。
-
-
-
-
-
-
-
-